TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030, indicating ...
We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a ...
Bullish option flow detected in Viking Therapeutics (VKTX) with 61,052 calls trading, 8x expected, and implied vol increasing over 32 points to ...
A rumor regarding Viking Therapeutics (VKTX) was highlighted in an alert sent to subscribers of Ben Harrington’s takeover-focused Betaville ...
Viking Therapeutics (VKTX) surges 10% on renewed takeover speculation, with Pfizer rumored as a potential buyer.
We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going to ...
Garmin reported fiscal fourth-quarter 2024 revenue growth of 23% year-on-year to $1.82 billion, beating the analyst consensus estimate of $1.70 billion. The GPS navigation and wearable technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback